Barclays maintains Overweight on Newmont, lowers target to $125

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Barclays analyst Richard Garchitorena maintains an Overweight rating on Newmont (NYSE: NEM) while reducing the price target from $133 to $125.

powered bylight_fuzz_icon
45607661

*this image is generated using AI for illustrative purposes only.

Barclays analyst Richard Garchitorena has adjusted the price target for Newmont while maintaining an Overweight rating on the stock. The firm lowered its price objective to $125, down from the previous $133, reflecting updated valuation metrics.

Newmont trades on the NYSE under the ticker symbol NEM.

Rating and Target Details

The following table outlines the revised analyst metrics:

Metric Value
Rating Overweight
Previous Price Target $133
New Price Target $125
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific valuation metrics prompted Barclays to lower Newmont's price target?

How might the current gold price environment influence Newmont's ability to meet the revised target?

Are there operational challenges or cost pressures affecting Newmont's profitability?

like19
dislike

TD Cowen upgrades Newmont to Buy, lowers target to $127

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

TD Cowen analyst Steven Green upgraded Newmont from Hold to Buy and lowered the price target to $127 from $129, signaling increased confidence despite the reduced valuation target.

powered bylight_fuzz_icon
44395518

*this image is generated using AI for illustrative purposes only.

TD Cowen analyst Steven Green has upgraded Newmont (NYSE: NEM) from Hold to Buy while lowering the price target to $127 from $129. The rating change signals increased confidence in the stock's performance potential despite the reduction in the valuation target.

Rating and Target Details

The research note shifts the brokerage's stance to positive, highlighting a revised investment thesis. The price target adjustment reflects a recalibration of expected returns based on current market conditions.

Metric Value
Rating Buy
Previous Rating Hold
Previous Price Target $129
New Price Target $127
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove the increased confidence in Newmont's performance potential despite the lower price target?

How might current market conditions influence Newmont's ability to meet the revised price target?

What are the potential risks or challenges Newmont could face in the near term?

like15
dislike

More News on Newmont Corp